Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1998-3-11
pubmed:abstractText
Gamma-mangostin, purified from the fruit hull of the medicinal plant Garcinia mangostana caused a parallel rightwards shift of the concentration/response curve for the contraction elicited by 5-hydroxytryptamine (5-HT) in the rabbit aorta (pA2 = 8.2) without affecting the contractile responses to KCl, phenylephrine (alpha1) or histamine (H1). The perfusion pressure response of rat coronary artery to 5-HT (5-HT2A) was reduced concentration dependently by gamma-mangostin (IC50 = 0.32 microM). 5-HT amplified, ADP-induced aggregation of rabbit platelets (5-HT2A) was inhibited by gamma-mangostin (IC50 = 0.29 microM), whereas that induced by thrombin was not affected, nor did gamma-mangostin affect 5-HT-induced contraction of the guinea-pig ileum (5-HT3)in the presence of 5-HT1, 5-HT2 and 5-HT4 receptor antagonists. Furthermore, 5-HT-induced contraction of the rat fundus (5-HT2B) and 5-HT-induced relaxation of the rabbit aorta in the presence of ketanserin (5-HT1) and carbachol-induced contraction of the guinea-pig ileum (muscarinic M3) were not affected by gamma-mangostin (5 microM). Gamma-mangostin inhibited [3H]spiperone binding to cultured rat aortic myocytes (IC50 = 3.5 nM). The Kd for [3H]spiperone binding was increased by gamma-mangostin (3 nM) from 11.7 to 27.4 nM without affecting Bmax. These results suggest that gamma-mangostin is a novel competitive antagonist, free from a nitrogen atom, for the 5-HT2A receptors in vascular smooth muscles and platelets.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0028-1298
pubmed:author
pubmed:issnType
Print
pubmed:volume
357
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
25-31
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9459569-Animals, pubmed-meshheading:9459569-Binding, Competitive, pubmed-meshheading:9459569-Dose-Response Relationship, Drug, pubmed-meshheading:9459569-Guinea Pigs, pubmed-meshheading:9459569-HIV Protease Inhibitors, pubmed-meshheading:9459569-Male, pubmed-meshheading:9459569-Muscle, Smooth, pubmed-meshheading:9459569-Muscle, Smooth, Vascular, pubmed-meshheading:9459569-Muscle Contraction, pubmed-meshheading:9459569-Perfusion, pubmed-meshheading:9459569-Plant Extracts, pubmed-meshheading:9459569-Platelet Aggregation Inhibitors, pubmed-meshheading:9459569-Rabbits, pubmed-meshheading:9459569-Rats, pubmed-meshheading:9459569-Rats, Wistar, pubmed-meshheading:9459569-Receptor, Serotonin, 5-HT2A, pubmed-meshheading:9459569-Receptors, Serotonin, pubmed-meshheading:9459569-Serotonin Antagonists, pubmed-meshheading:9459569-Spiperone, pubmed-meshheading:9459569-Xanthenes, pubmed-meshheading:9459569-Xanthones
pubmed:year
1998
pubmed:articleTitle
Gamma-mangostin, a novel type of 5-hydroxytryptamine 2A receptor antagonist.
pubmed:affiliation
Department of Pharmaceutical Molecular Biology, Faculty of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't